Varonis Systems: Friday’s Hot IPO
February 28, 2014 by Paul Ausick
Morgan Stanley, Barclays, Jefferies and RBC Capital were joint bookrunning managers for the offering and have an option on an additional 720,000 shares. At the IPO price, and including the overallotment, net proceeds from the IPO would be around $106 million. The company said in its filing that it is using the IPO to raise capital and to create a public market for its common stock.
Varonis makes a software platform that large enterprises can use to manage their unstructured data, such as letters, memos and emails — the stuff created by people that is difficult to map and manage. Varonis is the first technology company to hold an IPO in 2014, which has so far been the year of the biotechs.
On Thursday, medical equipment maker Lumenis Ltd. (NASDAQ: LMNS) came public at an IPO price of $12.50, below its expected range of $15 to $17. The Israel-based maker of minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications saw its share close at $12.15 Thursday, after rising to a high of $13.38 earlier in the day. The shares traded at $12.46 in the late morning on Friday.
But Varonis is blowing the doors off — up more than 77% at $38.84, after hitting an early peak of $39.75.
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.